OxyContin: Painkillers sold in Argentina face death claim in the United States

The accusation is directed against the owners of the laboratory that manufactures OxyContin. They are accused of having caused opioid addiction in this country.

The proliferation of opiates is unhindered in the United States and is growing along with a judicial scandal. Both substances and the pain reliever OxyContin appear as factors of what some call "the most serious drug crisis in the history of the country". A group of more than 500 cities, counties and tribes of Native Americans have filed a mbadive lawsuit against all members of the Sackler family, owners and managers of Purdue Pharma, the company that makes the company. OxyContin in this country.

Unlike other lawsuits, business owners are directly charged. The judicial initiative covers 26 states and eight indigenous tribes and accuses the Sacklers of knowingly violating the law to enrich themselves, while, according to the prosecution, thousands of people are dying.

The Sacklers owe their fortune primarily to Purdue Pharma, an unlisted company. "Eight members of the same family chose to choose what contributed to the opium epidemic," said the paper presented this week at the Southern District Federal Court in New York. "This nation is facing an unprecedented dependence on opiates that has been initiated and perpetuated by this family," he said.

The defendants responded in a statement that the allegations lacked support and were intended solely to create a state of opinion, not justice, to blame them throughout the crisis.

The situation in Argentina

In Argentina, Oxycontin is offered by Mundipharma Pharmaceuticals SRL, an American laboratory that was installed in our country in 2016.

"We continue to sell it," confirmed Clarín, interviewed by the laboratory manager, Martín Gravano, about the controversial drug.

Gravano explained that Mundipharma is an independent company of Purdue Pharma. As a result, "we do not have many reports" about what is happening in the US and "we do not communicate with them," he said.

Sources from Anmat confirmed to this newspaper that the painkiller is registered in the country, that it is sold under official prescription and that, on the official website of the body, it is informed of its components and its undesirable effects. In the United States, they preferred not to speak.

Oxycontin is an badgesic available in tablets of 10, 20 and 40 mg. It is indicated for the treatment of moderate to severe pain when the continuous administration of a pain reliever for 24 hours a day is required for a prolonged period.

"We do not sell it much – it's small (at the market level), for us.It's not widely used in Argentina.Each country has its peculiarities and in the US, it takes much more, "he said.

Regarding the American controversy, he stated that "it's not just with Oxycontin." All opioids generally produce side effects when they are misused – it's like everything: misused, any product can be complex. "

Gravano said that the product is sold in accordance with ANMAT regulations and stated: "We have not received any report" on the disadvantages badociated with its use in Argentina. As a result, he notes that they have not evaluated the withdrawal from the market.

Source: Clarín